Human FGF23 (C-terminal) multi-matrix ELISA BI-20702 from Biomedica Medizinprodukte GmbH

Product Specs
ItemHuman FGF23 (C-terminal) multi-matrix ELISA
CompanyBiomedica Medizinprodukte GmbH
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBI-20702
Quantity96 Tests (12x8 wells)
ApplicationsSandwich ELISA
Detection Range1.5-150.4 pg/ml (=0.2-20 pmol/l)
ReactivityHuman
Sample TypeSerum, EDTA plasma, heparin plasma, citrate plasma
Sensitivity0.6 pg/ml (=0.08 pmol/l)
Detection TargetFibroblast Growth Factor-23
Assay Timeovernight assay
DetectionColorimetric
Precisionintra-assay: 12%, inter-assay: 10%
Volume50 µl
Molecular Weight7.52 kDa
Regulatory StatusResearch use only
Diseasehypophosphatemia, vitamin D disorders, tumor-induced hypophosphatemia (TIO), autosomal dominant hypophosphatemia (ADHR), X-linked hypophosphatemia (XLH), fibrous dysplasia of the bone
NCBI Gene AliasesADHR, HPDR2, FGFN, HFTC2, PHPTC, HYPF
Research Areabone homeostasis, vitamin D metabolism, phosphate metabolism, cardiovascular homeostasis
Gene Namefibroblast growth factor 23, FGF23

Add to Compare List

Biomedica Medizinprodukte GmbH

Divischgasse 4

1210 Vienna

Austria

Phone: + 43 1 291 07 45
Fax: + 43 1 291 07 63 89

Email: info@bmgrp.com

Company Profile

Website: www.bmgrp.com

(1) Dynamic Evaluation of Vitamin D Metabolism in Post-Bariatric PatientsJournal of Clinical MedicineDecember 19, 2023Alexandra Povaliaeva, Artem Zhukov, Alina Tomilova, Axenia Bondarenko, Maksim Ovcharov, Mariya Antsupova, Vitaliy Ioutsi, Ekaterina Shestakova, Marina Shestakova, Ekaterina Pigarova, et al.

(2) Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitusDiabetes/metabolism research and reviewsNovember 1, 2023Hocher CF, Chen X, Zuo J, Horvathova K, Hocher B, Krämer BK, Chu C.

(3) Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohortBone researchOctober 20, 2023Reimer KC, Nadal J, Meiselbach H, Schmid M, Schultheiss UT, Kotsis F, Stockmann H, Friedrich N, Nauck M, Krane V, et al.an intra-assay variation ≤3%. C-terminal FGF23 was measured by ELISA (Biomedica Immunoassays; Cat# BI-20702) with an LOD of 0 pmol·L–1 + 3 standard deviations (SD) of 0.07 pmol·L–1 and an intra-assay variation

(4) Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort StudiesThe Journal of Clinical Endocrinology & MetabolismSeptember 18, 2023Amarens van der Vaart, Coby Eelderink, André P van Beek, Stephan J L Bakker, Peter R van Dijk, Martin H de Borstsamples using the FGF23 Multi-Matrix enzyme-linked immunosorbent assay (ELISA) kit (Biomedica catalog No. BI-20702, RRID:AB_2935690). This ELISA has interassay and intra-assay coefficients of variation of less than

(5) Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or InfliximabInflammatory bowel diseasesAugust 1, 2023Loveikyte R, Bourgonje AR, van der Reijden JJ, Bulthuis MLC, Hawinkels LJAC, Visschedijk MC, Festen EAM, van Dullemen HM, Weersma RK, van Goor H, et al.(R&D Systems; DHP250), sTfR (BioVendor; RD194011100), iFGF-23 (Biomedica; BI-20700), cFGF-23 (Biomedica; BI-20702). Custom electrochemiluminescence assays (Meso Scale Discovery; Meso Scale Diagnostics) were used to

(6) Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipientsFrontiers in endocrinologyJanuary 1, 2023Zuo J, Hasan AA, Hocher CF, Kalk P, Kleuser B, Krämer BK, Hocher B.available ELISA used to measure cFGF23 was the FGF23 (C-terminal) multi-matrix ELISA with catalog number BI-20702, produced by Biomedica in Austria, according to the manufacturer’s instructions (https://www.bmgrp.com/wp-content/uploads/2019/03/bi-20702-fgf23-elisa-validation-data-150306.pdf).

(7) Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infantsFrontiers in geneticsJanuary 1, 2023Enlund-Cerullo M, Holmlund-Suila E, Valkama S, Hauta-Alus H, Rosendahl J, Andersson S, Pekkinen M, Mäkitie O.

(8) Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosisFront Endocrinol (Lausanne)September 8, 2022Petra Loid, Helena Hauta-alus, Outi Mäkitie, Per Magnusson, Riikka E. MäkitieKainos Laboratories, Inc., Tokyo, Japan), and C-terminal FGF23 (cFGF23) was also assessed by ELISA (Cat# BI-20702, Biomedica, Vienna, Austria). Both dickkopf-1 (DKK1) (Cat# BI-20413) and sclerostin (Cat# BI-20492)

(9) C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survivalBMC NephrologyDecember 1, 2021Chang Chu, Saban Elitok, Shufei Zeng, Yingquan Xiong, Carl-Friedrich Hocher, Ahmed A. Hasan, Bernhard K. Krämer, Berthold HocheriFGF23 were measured with commercially available ELISA [FGF23 (C-terminal) multi-matrix ELISA, cat. no. BI-20702, Biomedica, Austria and FGF23 (intact) human ELISA, cat. no.BI-20700, Biomedica, Austria) according

(10) Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label StudyNutrientsJuly 2, 2021Angelo Fassio, Davide Gatti, Maurizio Rossini, Camilla Benini, Elena Fracassi, Eugenia Bertoldo, Ombretta Viapiana, Stefano Milleri, Matteo Gatti, Giovanni AdamiBiomedica, BI-20413), Sclerostin (SOST, Biomedica, BI-20492), and FGF-23 (FGF23 C-terminal, Biomedica, BI-20702). Serum PINP, CTX-I, PTH, and BAP were measured by the IDS-ISYS Multi-Discipline automated analyzer

(11) Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 StudyClinical biochemistryFebruary 1, 2018Lyngbakken MN, Pervez MO, Brynildsen J, Pedersen MH, Sølvernes J, Christensen G, Høiseth AD, Omland T, Røsjø H.

(12) Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old ChildrenThe Journal of clinical endocrinology and metabolismDecember 1, 2017Holmlund-Suila E, Enlund-Cerullo M, Valkama S, Hauta-Alus H, Rosendahl J, Helve O, Hytinantti T, Viljakainen H, Andersson S, Mäkitie O.

(13) Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patientsNephrology (Carlton, Vic.)November 16, 2017Kazuomi Yamashita, Sonoo Mizuiri, Yoshiko Nishizawa, Shigemoto Kenichiro, Shigehiro Doi, Takao Masaki

(14) Fibroblast Growth-factor 23 and Calcium-binding Proteins are not Associated with Chronic Itch in Patients on HaemodialysisActa dermato-venereologicaMarch 10, 2017Mettang T, Kunzmann K, Roth HJ, Weisshaar E.

(15) FGF23 and vitamin D metabolism in chronic kidney disease - mineral bone disorderBone AbstractsApril 21, 2016Isabelle Piec, Allison Chipchase, Holly Nicholls, Christopher Washbourne, Jonathan Tang, William D. Fraserenzyme-linked immunosorbent assay (ELISA) 2nd generation from Immunotopics Inc., CA. - c-terminal FGF23 (cat# BI-20702) was a sandwich enzyme immunoassay from Biomedica. Concentrations were calculated using 1pmol/L = 0.133pg/mL. -

(16) Skeletal tuberculosis: diagnosis of three unusual casesClinical orthopaedics and related researchJanuary 1, 1972P Jokl, A H Goodman

Be the First to Write a Review!

Bench Tips for Optimizing ELISA: It All Comes Out in the Wash
August 22, 2013
This article will provide you with tips on washing your ELISA plates using an automated plate washer, with the goal of avoiding high background and high variation (between plates and between replicate wells). read more

Human FGF23 (C-terminal) ELISA

Human FGF23 (C-terminal) multi-matrix ELISA from Biomedica Medizinprodukte GmbH

Description

Biomedica Medizinprodukte GmbH

Citations (16)

Reviews

Bench Tips

Bench Tips for Optimizing ELISA: It All Comes Out in the Wash

Human FGF23 (C-terminal) multi-matrix ELISA from Biomedica Medizinprodukte GmbH

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map